Literature DB >> 9323952

Favorable visual outcome in cryptococcal meningitis.

R C Ferreira1, G Phan, J B Bateman.   

Abstract

PURPOSE: To describe an unusual, favorable visual outcome in a patient with lupus erythematosus and cryptococcal meningitis and to present bilateral superior oblique muscle paresis.
METHODS: Case report. A 15-year-old girl with lupus erythematosus and cryptococcal meningitis had bilateral superior oblique paresis, bilateral optic nerve head swelling, and increased intracranial pressure. She developed a visual acuity of no light perception in the right eye.
RESULTS: Treatment with oral fluconazole, acetazolamide, and dexamethasone, as well as repeated lumbar punctures to reduce intracranial pressure, was followed by recovery to a visual acuity of 20/20 in both eyes and normal ocular motility.
CONCLUSION: With appropriate treatment, visual loss associated with cryptococcal meningitis may have a favorable outcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323952     DOI: 10.1016/s0002-9394(14)70877-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Optic nerve sheath fenestration in cryptococcal meningitis.

Authors:  Tatyana Milman; Neena Mirani; Roger E Turbin
Journal:  Clin Ophthalmol       Date:  2008-09

Review 2.  Extensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and Strategies.

Authors:  Onyema Ogbuagu; Merceditas Villanueva
Journal:  Infect Dis Rep       Date:  2014-11-19

3.  Visual loss in HIV-associated cryptococcal meningitis: A case series and review of the mechanisms involved.

Authors:  Anand Moodley; William Rae; Ahmed Bhigjee
Journal:  South Afr J HIV Med       Date:  2015-10-16       Impact factor: 2.744

4.  Early clinical and subclinical visual evoked potential and Humphrey's visual field defects in cryptococcal meningitis.

Authors:  Anand Moodley; William Rae; Ahmed Bhigjee; Cathy Connolly; Natasha Devparsad; Andrew Michowicz; Thomas Harrison; Angela Loyse
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.